-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Applied Genomics in MPD

Program: Education Program
Session: Myeloproliferative Disorders: Too Many Cells, Too Few Therapies - How Do We Choose?
Hematology Disease Topics & Pathways:
Diseases, Therapies, MPN, Polycythemia vera, thrombocythemia, Myeloid Malignancies, Clinically relevant
Monday, December 7, 2020, 8:55 AM-9:00 AM

Alison R. Moliterno, MD

Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Disclosures: Moliterno: MPNRF: Research Funding; Pharmessentia: Consultancy.

OffLabel Disclosure:

See more of: Myeloproliferative Disorders: Too Many Cells, Too Few Therapies - How Do We Choose?
See more of: Education Program
<< Previous Presentation | Next Presentation >>